# Non-Surgical Debridement

Canonical: https://abierto.us/opportunities/bardacbrn11122024ves

- Solicitation number: BARDA-CBRN-11122024-VES
- Notice type: Sources sought
- Status: Closed. Deadline was December 2, 2024 at 3:00 PM EST
- Department: Department of Health and Human Services
- Agency: Office of Assistant Secretary for Preparedness and Response
- Contracting office: Barda - Aspr / Daappo / Barda DCMA (75A501)
- NAICS: 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Product or service code: AN13 Health R&D Services; Health Care Services; Experimental Development
- Place of performance: Washington, District of Columbia
- County: District of Columbia (FIPS 11001). https://abierto.us/counties/district-of-columbia-dc-11001
- City: Washington. https://abierto.us/cities/washington-dc-1150000
- First posted: November 12, 2024
- Last posted: November 12, 2024
- SAM.gov: https://sam.gov/workspace/contract/opp/2e5d31f86622466d9009bea559b10b2e/view

## Description

PURPOSE The Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS), is issuing this Sources Sought Notice (SSN) to collect information on specific product and service suppliers supporting the mission.

Information collected from this SSN serves as market research whereby BARDA could partner with one or more organizations to achieve the preparedness goals set forth by the U.S. Government (USG). The information collected in response to this SSN is intended to strengthen BARDA’s understanding of the current and future marketplace. This notice seeks information from Other than Small Businesses (OTSB) and Small Businesses (SB) regarding their qualifications, experience, and capabilities.

BARDA’s mission is primarily to build national preparedness by developing a broad range of medical countermeasures (MCM) which mitigate medical consequences from various threats. Under this SSN, BARDA is specifically seeking information on FDA approved, enzymatic debridement products for non-surgical removal of necrotic eschar tissue from severe burns or those that may be approved in the next 2 years. The technologies sought are expected to function in U.S. burn centers.

Burn debridement products that can be well-integrated into routine burn care settings inherently build national preparedness by creating the capability to use these tools during mass casualties involving burn injuries. (See Objective section below for details).

## Publications

- November 12, 2024: Sources sought, due December 2, 2024 at 3:00 PM EST. Notice 2e5d31f86622466d9009bea559b10b2e. https://sam.gov/workspace/contract/opp/2e5d31f86622466d9009bea559b10b2e/view

## Points of contact

- Veronica Stroud, veronica.stroud@hhs.gov, 2027313103
- Yifan Yang, yifan.yang@hhs.gov

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/bardacbrn11122024ves.